“AI holds enormous promise for the future of medicine. We’re actively developing a new regulatory framework to promote innovation in this space and support the use of AI-based technologies.” – Dr. Scott Gottlieb, former FDA Commissioner, April 2018
This whitepaper explores how machine learning and AI can help overcome challenges the life science industry is currently facing in the validation of clinical data. Traditional validation processes in any therapeutic area can be highly automated, for example, eliminating time-consuming, manual cross checks and mitigating risks before they develop. Verify, an AI-based technology, increases the efficiency of clinical trial data validation and regulatory submissions, expediting the availability of life-saving therapies.
Read the full whitepaper here.
